Cognición y modelos predictivos de calidad de vida en enfermedades neurológicas

De Brouwer E,Becker T,Moreau Y,Havrdova EK,Trojano M,Eichau S et al. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression (vol 208, 106180, 2021). Comput. Meth. Programs Biomed. 2022. 213106479. IF:5,428. (1).

Rodrigo Armenteros P, Uterga Valiente JM, Zabala Arco J, Taramundi Argueso S, Anton Mendez L, Gomez Muga JJ et al. Optic neuropathy in a patient with COVID-19 infection. Acta Neurol Belg. 2021; 122(3): 789-791. DOI:10.1007/s13760-021-01600-w.

Erburu Iriarte M, Rodrigo Armenteros P, Oyarzun Irazu I, Aranzabal Alustiza I, Silvarrey Rodriguez S, Anton Mendez L et al. Chronic severe methanol intoxication after repeated mask cleansing for fear to COVID-19 - a new risk of coronaphobia. Eur J Neurol. 2021; 28(10): 3448-3451. DOI:10.1111/ene.14779.

García Azorín D, Abildúa M, Aguirre M, Fernández SF, Moncó JCG, Guijarro Castro C et al. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry. J Neurol Sci. 2021; 423: 117283-117283. DOI:10.1016/j.jns.2020.117283.

Garcia Monco JC, Cabrera Muras A, Erburu Iriarte M, Rodrigo Armenteros P, Collia Fernandez A, Arranz Martinez J et al. Neurologic Manifestations in a Prospective Unselected Series of Hospitalized Patients With COVID-19. Neurol-Clin Pract. 2021; 11(2): 64-72. DOI:10.1212/CPJ.0000000000000913.

Fernandez AC, Anton BH, Garcia Monco JC. Progressive Ataxia and Downbeat Nystagmus in the Adult C. Magnesium depletion. JAMA Neurol. 2021; 78(8): 1018-1019. DOI:10.1001/jamaneurol.2021.1205.

De Brouwer E, Becker T, Moreau Y, Havrdova EK, Trojano M, Eichau S et al. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression. Comput Meth Programs Biomed. 2021; 208: 106180-106180. DOI:10.1016/j.cmpb.2021.106180.

Guasp M, Landa J, Martinez Hernandez E, Sabater L, Iizuka T, Simabukuro M et al. Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies. Neurol-Neuroimmunol Neuroinflammation. 2021; 8(5). DOI:10.1212/NXI.0000000000001053.

Gaig C, Compta Y, Heidbreder A, Marti MJ, Titulaer MJ, Crijnen Y et al. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. Neurology. 2021; 97(14): 1367-1381. DOI:10.1212/WNL.0000000000012639.

Butzkueven H, Spelman T, Ozakbas S, Boz C, Buzzard K, Skibina O et al. Real-world experience with ocrelizumab in relapsing multiple sclerosis: insights from the MSOCR-R cohort, an MSBase registry sub-study. Mult Scler J. 2021; 27(2_SUPPL): 104-106

Butzkueven H, Spelman T, Hodgkinson S, Madueno SE, Izquierdo G, Buzzard K et al. Real-world experience with cladribine in the MSBase Registry. Mult Scler J. 2021; 27(2_SUPPL): 681-683

Castillo Trivino T, Carrascal DP, Iniguez AE, Martinez MO, Martinez LM, Arruti M et al. Efficacy and safety of alemtuzumab in clinical practice in Northeastern Spain. Mult Scler J. 2021; 27(2_SUPPL): 717-718

Roos I, Sharmin S, Ozakbas S, Horakova D, Havrdova EK, Boz C et al. Comparison of the effectiveness of ocrelizumab vs interferons, fingolimod and natalizumab on relapses in relapsing-remitting multiple sclerosis. Mult Scler J. 2021; 27(2_SUPPL): 778-780

Muras AC, Irazabal BA, Sanchez JG, Romero IC, Deza E, Gonzalez AB et al. Topic: AS01 Acute Stroke Therapy, Management and Prehospital Care MECHANICAL THROMBECTOMY FOR ACUTE MIDDLE CEREBRAL ARTERY M2 SEGMENT OCCLUSION. EXPERIENCE AND RESULTS IN A TERTIARY CENTER. Int J Stroke. 2021; 16(2_SUPPL): 83-83

Diez Cirarda M, Gabilondo I, Ibarretxe Bilbao N, Gomez Esteban JC, Kim J, Lucas Jimenez O et al. Contributions of sex, depression, and cognition on brain connectivity dynamics in Parkinson's disease. npj Parkinsons Dis. 2021; 7(1). DOI:10.1038/s41531-021-00257-9.

Mena J, Alloza I, Tulloch Navarro R, Aldekoa A, Díez García J, Villanueva Etxebarria A et al. Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55-IL6ST Gene Region in Immature Dendritic Cells. Front Immunol. 2021; 12: 816930-816930. DOI:10.3389/fimmu.2021.816930.

Harding Forrester S, Roos I, Sharmin S, Diouf I, Malpas C, Nguyen AL et al. Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis. Neurology. 2021; 96(15)

Diouf I, Malpas C, Horakova D, Havrdova E, Patti F, Shaygannejad V et al. Variability of the Response to Immunotherapy Among Sub-groups of Patients With Multiple Sclerosis. Neurology. 2021; 96(15)

Dominguez Gonzalez C, Mroczek M, Kapetanovic S, AlSaman A, Gogoi R, Charlton R et al. Novel diagnostic index test CATCH2 improves detection of acute vestibular stroke (EMVERT study). Eur J Neurol. 2021; 28: 89-89

Dominguez Gonzalez C, Mroczek M, Kapetanovic S, AlSaman A, Gogoi R, Charlton R et al. Biallelic variants in the molecular chaperone DNAJB4 are a genetic cause of myopathy with respiratory muscle involvement. Eur J Neurol. 2021; 28: 90-90

Costa JV, Monica P, Nascimento A, Kapetanovic S, Moreno A, Hervas D et al. Nusinersen treatment in adult patients with 5q spinal muscular atrophy. Eur J Neurol. 2021; 28: 832-832

Vitkova M, Diouf I, Malpas C, Horakova D, Havrdova EK, Patti F et al. Association of Latitude and Exposure to Ultraviolet B Radiation with Severity of Multiple Sclerosis. Neurology. 2021; 96(15)

Toca AB, Arroyo AM, Sainz AR, Martinez JA, Zarraga IS, Calle IA et al. Mutations in MME gene causing distal hereditary motor neuropathy and MCI-AD. J Neurol Sci. 2021; 429: 92-92. DOI:10.1016/j.jns.2021.118990.

Pinedo A,Vidorreta L,Arranz JJ,Sustacha I,Barquin A,Anton A,Garcia C,Gomez MA. DRIP-AND-SHIP MODEL FOR STROKE TREATMENT IS VALID: TIME AND PATIENT SELECTION IS WHAT MATTERS. Int. J. Stroke. 2020. 15. (1_SUPPL):p. 332-332. IF:5,266. (1).

Pinedo A,Vidorreta L,Arranz JJ,Sustacha I,Barquin A,Anton A,Garcia C,Gomez MA. ANTERIOR CIRCULATION FUTILE RECANALIZATION PREDICTORS IN A DRIPAND SHIP MODEL OF ISCHEMIC STROKE TREATMENT. Int. J. Stroke. 2020. 15. (1_SUPPL):p. 427-427. IF:5,266. (1).

Cabrera A,Garcia J,Collia A,Gil MDC,Rodrigo P,Erburu M,Sainz A,Morales E,Bilbao A,Garcia JC. MECHANICAL THROMBECTOMY IN ELDERLY PATIENTS. A COMPARATIVE STUDY IN A TERTIARY CENTER. Int. J. Stroke. 2020. 15. (1_SUPPL):p. 122-122. IF:5,266. (1).

Sustacha I,Barquin A,Vidorreta L,Arranz JJ,Rodriguez A,Ruisanchez A,Gomez MA,Garcia JC. PERFUSION ABNORMALITIES ON NEUROIMAGING: MIGRAINE OR STROKE?. Int. J. Stroke. 2020. 15. (1_SUPPL):p. 287-287. IF:5,266. (1).

Collia A,Gil MDC,Cabrera A,Sainz A,Erburu M,Rodrigo P,Garcia J,Morales E,Bilbao A,Garcia J. THROMBECTOMY IN STROKE WITH UNKNOWN ONSET: TWO-YEAR EXPERIENCE IN A TERCIARY CENTER. Int. J. Stroke. 2020. 15. (1_SUPPL):p. 428-428. IF:5,266. (1).

Sanchez I,Lucas O,Pena J,Ojeda N,Gomez JC,Gomez MA,Vazquez R,Foncea N,Ibarretxe N. PREDICTORS OF QUALITY OF LIFE IN PARKINSON'S DISEASE. Parkinsonism Relat. Disord. 2020. 79. p. 18-18. IF:4,891. (1).

Cabrera A,Carmona MM,Collia A,Uterga JM,Anton L,Garcia JC. Bilateral Facial Nerve Palsy associated with COVID-19 and Epstein-Barr Virus co-infection. Eur. J. Neurol. 2020. 28. (1):p. 358-360. IF:6,089. (1).

Collia A,Garcia JM,Rivera P,Fernandez P,Rodrigo P,Torre I,Castillo B,Gomez JJ,Gil MDC,Garcia JC. Recurrent Vertebrobasilar Strokes Associated With Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE). Neurologist. 2020. 25. (5):p. 131-136. .

Perez M,Amayra I,Lazaro E,Garcia M,Martinez O,Caballero P,Berrocoso S,Lopez JF,Al M,Rodriguez AA,Luna P,Varona L. Intrusion errors during verbal fluency task in amyotrophic lateral sclerosis. PLoS One. 2020. 15. (5):e0233349. IF:3,240. (2).

Le M,Malpas C,Sharmin S,Horakova D,Havrdova E,Trojano M,Izquierdo G,Eichau S,Ozakbas S,Lugaresi A,Prat A,Girard M,Duquette P,Larochelle C,Alroughani R,Bergamaschi R,Sola P,Ferraro D,Grammond P,Maison FG,Terzi M,Boz C,Hupperts R,Butzkueven H,Pucci E,Granella F,Van V,Soysal A,Yamout BI,Lechner J,Spitaleri D,Ampapa R,Turkoglu R,Iuliano G,Ramo C,Sanchez JL,Sidhom Y,Gouider R,Shaygannejad V,Prevost J,Altintas A,Fragoso YD,McCombe PA,Petersen T,Slee M,Barnett MH,Vucic S,Van der Walt A,Kalincik T,MSBase GRP. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis. Mult. Scler. J. 2020. 27. (5):p. 755-766. IF:6,312. (1).

Zahia S,Garcia B,Saralegui I,Fernandez B. Dyslexia detection using 3D convolutional neural networks and functional magnetic resonance imaging. Comput. Meth. Programs Biomed. 2020. 197. p. 105726-105726. IF:5,428. (1).

Garcia JC,Cabrera A,Collia A,Erburu M,Rodrigo P,Oyarzun I,Martinez D,Bilbao A,Carmona M,Caballero I,Gomez M. Neurological reasons for consultation and hospitalization during the COVID-19 pandemic. Neurol. Sci. 2020. 41. (11):p. 3031-3038. IF:3,307. (2).

Kunchok A,Lechner J,Granella F,Trojano M,Alroughani R,Sola P,Ferraro D,Lugaresi A,Onofrj M,Ozakbas S,Izquierdo G,Grammond P,Sanchez JL,Van B,Boz C,Pucci E,McCombe P,Grand'Maison F,Spitaleri D,Vucic S,Hupperts R,Jokubaitis V,Sormani MP,Butzkueven H,Kalincik T,MSBase GRP. Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score. Mult. Scler. J. 2020. 27. (5):p. 695-705. IF:6,312. (1).

Kalincik T,Diouf I,Sharmin S,Malpas C,Spelman T,Horakova D,Havrdova EK,Trojano M,Izquierdo G,Lugaresi A,Prat A,Girard M,Duquette P,Grammond P,Jokubaitis V,van der Walt A,Grand'Maison F,Sola P,Ferraro D,Shaygannejad V,Alroughani R,Hupperts R,Terzi M,Boz C,Lechner J,Pucci E,Van V,Granella F,Bergamaschi R,Spitaleri D,Slee M,Vucic S,Ampapa R,McCombe P,Ramo C,Prevost J,Olascoaga J,Cristiano E,Barnett M,Saladino ML,Sanchez JL,Hodgkinson S,Rozsa C,Hughes S,Moore F,Shaw C,Butler E,Skibina O,Gray O,Kermode A,Csepany T,Singhal B,Shuey N,Piroska I,Taylor B,Simo M,Sirbu C,Sas A,Butzkueven H,MSBase G. Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years. Neurology. 2020. 96. (5):e783-e797. IF:8,770. (1).

Rodrigo P,Uterga JM,Zabala J,Taramundi S,Erburu M,Anton L,Gomez JJ,Garcia JC. Non-convulsive status epilepticus in a patient with COVID-19 infection. Clin. Neurophysiol. 2020. 131(11):p. 2588-2590. IF:3,708. (2).

Garcia-Monco JC, Benach JL. Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.. Ann Neurol. 2019; 85(1): 21 - 31. FI: 9,496(Q1). DOI: 10.1002/ana.25389.

Castanedo-Vazquez D, Bosque-Varela P, Sainz-Pelayo A, Riancho J. Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration.. J Neurol. 2019; 266(1): 27 - 36. FI: 4,204(Q1). DOI: 10.1007/s00415-018-8919-3.

Carlos Garcia-Monco, Juan, Gonzalo Garcia, Aranzazu, Garcia Sanchez, Juan Manuel, Martinez Vazquez, Maria Mar, Munoz Tena, Ramon, Olaldecoa Alonso, Ana Isabel, Garmendia Saavedra, Goikoana, Gallo Fernandez, Joseba Inaki, Cairo Rojas, Maria Carmen, Abad Gar, Roberto. The stroke pathway: an integrated approach to health care of stroke patients.. Int. J. Integr. Care. 2019; 19(1). FI: 2,489(Q2). DOI: 10.5334/ijic.s3544.

Gomez Beldarrain, Marian, Santos Ibanez, Amaia, Maldonado Fernandez, Maria Carmen, Martinez Bengoechea, Maria Jose, Carlos Garcia-Monco, Juan. An integrated, cost-effective efficient chain to deliver botulinum toxin in optimal conditions.. Int. J. Integr. Care. 2019; 19(1). FI: 2,489(Q2). DOI: 10.5334/ijic.s3547.

Leira Y., Pozo-Rosich P., Torres-Ferrús M., Orlandi M., Láinez J.M., Álvaro L.C., Monzón M.J., Guerrero Á., García-Azorín D., Belvís R., González-Oria C., Gago-Veiga A.B., Latorre G., Santos S., Cuadrado M.L., Blanco J., Leira R., D'Aiuto F.. Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain. Odontology. 2019; 107(4): 530 - 535. FI: 1,813(Q2). DOI: 10.1007/s10266-019-00430-w.

Brown, J. William L., Coles, Alasdair, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Trojano, Maria, Lugaresi, Alessandra, Bergamaschi, Roberto, Grammond, Pierre, Alroughani, Raed, Hupperts, Raymond, McCombe, Pamela, Van Pesch, Vincent, Sola, Patrizia, Ferraro, Diana, Grand'Maison, Francois, Terzi, Murat, Lechner-Scott, Jeannette, Flechter, Schlomo, Slee, Mark, Shaygannejad, Vahid, Pucci, Eugenio, Granella, Franco, Jokubaitis, Vilija, Willis, Mark, Rice, Claire, Scolding, Neil, Wilkins, Alastair, Pearson, Owen R., Ziemssen, Tjalf, Hutchinson, Michael, Harding, Katharine, Jones, Joanne, McGuigan, Christopher, Butzkueven, Helmut, Kalincik, Tomas, Robertson, Neil, Onofrj, Marco, De Luca, Giovanna, Di Tommaso, Valeria, Travaglini, Daniela, Pietrolongo, Erika, di Ioia, Maria, Farina, Deborah, Mancinelli, Luca, Hodgkinson, Suzanne, Oreja-Guevara, Celia, Boz, Cavit, Prevost, Julie, Olascoaga, Javier, Van Wijmeersch, Bart, Barnett, Michael, Verheul, Freek, Rojas, Juan Ingacio, Spitaleri, Daniele, Rio, Maria Edite, Taylor, Bruce, Luis Sanchez-Menoyo, Jose, Ramo-Tello, Cristina, Solaro, Claudio, Csepany, Tunde, Iuliano, Gerardo, Skibina, Olga, Petersen, Thor, Bolanos, Ricardo Fernandez, Sidhom, Youssef, Riadh, Vucic, Steve, Macdonell, Richard, Sempere, Angel Perez, Simo, Magdolna, Kister, Ilya, Shuey, Neil, Radek, Dominguez, Jose Andres, Pia Amato, Maria, Saladino, Maria Laura, Kermode, Allan, Butler, Ernest, Moore, Fraser, Hughes, Stella, McDonnell, Gavin, Piroska, Imre, Yamout, Bassem, Soysal, Aysun, Ozakbas, Serkan, Zwanikken, Cees, MSBase Study Grp. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. JAMA-J. Am. Med. Assoc.. 2019; 321(2): 175 - 187. FI: 51,273(Q1). DOI: 10.1001/jama.2018.20588.

Lorscheider, J., Kuhle, J., Izquierdo, G., Lugaresi, A., Havrdova, E., Horakova, D., Hupperts, R., Duquette, P., Girard, M., Prat, A., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Trojano, M., Ramo-Tello, C., Lechner-Scott, J., Pucci, E., Solaro, C., Slee, M., Van Pesch, V., Sanchez Menoyo, J. L., van der Walt, A., Butzkueven, H., Kappos, L., Kalincik, T., MSBase Study Grp. Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study. Eur. J. Neurol.. 2019; 26(2): 363 - 370. FI: 4,387(Q1). DOI: 10.1111/ene.13824.

Olascoaga-Arrate, A, Freijo-Guerrero, MM, Fernandez-Maiztegi, C, Azkune-Calle, I, Silvarino-Fernandez, R, Fernandez-Rodriguez, M, Mateos-Del Pino, M, Anievas-Elena, A, Iturraspe-Gonzalez, I, Perez-Diez, Y, Ruiz-Fernandez, R. Relacion del nivel de estudios con la supervivencia en el primer año tras un ictus isquemico. Rev. Neurologia. 2019; 68(4): 147 - 154. FI: 0,485(Q4). DOI: 10.33588/rn.6804.2018254.

Olascoaga Arrate A, Freijo Guerrero MM, Fernández Maiztegi C, Azkune Calle I, Silvariño Fernández R, Fernández Rodríguez M, Vazquez Naveira P, Anievas Elena A, Iturraspe González I, Pérez Díez Y, Ruiz Fernández R. Use of emergency medical transport and impact on time to care in patients with ischaemic stroke. Neurologia. 2019; 34(2): 80 - 88. FI: 2,038(Q3). DOI: 10.1016/j.nrl.2016.11.004.

Garcia-Monco, Juan Carlos, Sommer, Katherine, Afanador, Lauriaselle, Franznick, Dana, Asmus, Peter, Becker, Veit, Boeger, Andrea, Buschmann, Dirk, Dulcius, Andrea, Ebke, Markus, Engelmann, Christoph, Eser, Anna-Katharina, Foerster, Heike, Freitag, Frank, Gaul, Charly, Gendolla, Astrid, Gerlach, Klaus, Gessler, Martin, Goebel, Hartmut, Guenther, Olaf, Halbgewachs, Frank, Hamacher, Juergen, Haendel, Dorothea, Haslbeck, Matthias, Heinicke, Volker, Hellwig, Bernhard, Herbst, Heinz Peter, Hesselbarth, Sabine, Jaeger, Hanno, Jansen, Jan-Peter, Jost, Wolfgang, Kaube, Holger, Kirchhoefer, Ulrike, Kiszka, Michael, Klimpel, Lothar, Koehler, Ulrike, Kollewe, Katja, Kornhuber, Anselm, Krause, Michaela, Krome, Kathrin, Kukowski, Borries, Kupsch, Andreas, Leger, Roland, Lux, Eberhard Albert, Mueller, Gabriele, Mueller-Schwefe, Gerhard, Nautscher-Timmermann, Stephan, Noack, Dietmar Walter, Oberling, Manfred, Palutke, Ingo, Pinkhardt, Elmar, Resch, Sonja, Roeder, Matthias, Scheunemann, Juliane, Schwittay, Andreas, Strauss, Erik, Straube, Andreas, Strickling, Nicole, Ulzheimer, Jochen, Wrenger, Klaus, Zug, Hans-Dieter, De Cesaris, Francesco, Grazzi, Licia, Martelletti, Paolo, Sonnervik, Julie, Artemenko, Ada, Azimova, Julia, Doronina, Olga, Falkovskiy, Ilya, Orlova, Olga, Pascual Gomez, Julio, Antonio Heras, Jose, Iglesias, Fernando, Jurado, Carmen, Leira, Rogelia, Johansson, Rune, Lofving, Hakan, Tedroff, Joakim, Ahmed, Fayyaz, Al Din, Amir, Davies, Brendan, REPOSE Principal Investigators. An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study. J Headache Pain. 2019; 20: 26. FI: 3,918(Q1). DOI: 10.1186/s10194-019-0976-1.

Anguizola-Tamayo, David, Bocos-Portillo, Jone, Pardina-Vilella, Lara, Rodriguez-Sainz, Aida, Vicente-Olabarria, Inigo, Martinez, Eduardo, Gomez-Beldarrain, Marian, Carlos Garcia-Monco, Juan. Psychosis of dual origin in HIV infection Viral escape syndrome and autoimmune encephalitis. Neurol.-Clin. Pract.. 2019; 9(2): 178 - 180. FI: (Q). DOI: 10.1212/CPJ.0000000000000582.

Kalincik, Tomas, Havrdova, Eva Kubala, Horakova, Dana, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Ozakbas, Serkan, Kappos, Ludwig, Kuhle, Jens, Terzi, Murat, Lechner-Scott, Jeannette, Boz, Cavit, Grand'Maison, Francois, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Granella, Franco, Trojano, Maria, Bergamaschi, Roberto, Pucci, Eugenio, Turkoglu, Recai, McCombe, Pamela A., Van Pesch, Vincent, Van Wijmeersch, Bart, Solaro, Claudio, Ramo-Tello, Cristina, Slee, Mark, Alroughani, Raed, Yamout, Bassem, Shaygannejad, Vahid, Spitaleri, Daniele, Luis Sanchez-Menoyo, Jose, Ampapa, Radek, Hodgkinson, Suzanne, Karabudak, Rana, Butler, Ernest, Vucic, Steve, Jokubaitis, Vilija, Spelman, Tim, Butzkueven, Helmut. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 2019; 90(4): 458 - 468. FI: 8,272(Q1). DOI: 10.1136/jnnp-2018-319831.

Kortazar-Zubizarreta I, Pinedo-Brochado A, Azkune-Calle I, Aguirre-Larracoechea U, Gomez-Beldarrain M, Garcia-Monco JC. Predictors of in-hospital mortality after ischemic stroke: A prospective, single-center study.. Health Sci Rep. 2019; 2(4): e110. FI: (Q). DOI: 10.1002/hsr2.110.

Alonso-Jimenez A, Kroon RHMJM, Alejaldre-Monforte A, Nuñez-Peralta C, Horlings CGC, van Engelen BGM, Olivé M, González L, Verges-Gil E, Paradas C, Márquez C, Garibaldi M, Gallano P, Rodriguez MJ, Gonzalez-Quereda L, Dominguez Gonzalez C, Vissing J, Fornander F, Eisum AV, García-Sobrino T, Pardo J, García-Figueiras R, Muelas N, Vilchez JJ, Kapetanovic S, Tasca G, Monforte M, Ricci E, Gomez MT, Bevilacqua JA, Diaz-Jara J, Zamorano II, Carlier RY, Laforet P, Pelayo-Negro A, Ramos-Fransi A, Martínez A, Marini-Bettolo C, Straub V, Gutiérrez G, Martín MA, Morís G, Fernández-Torrón R, Lopez De Munaín A, Cortes-Vicente E, Querol L, Rojas-García R, Illa I, Diaz-Manera J. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy. J. Neurol. Neurosurg. Psychiatry. 2019; 90(5): 576 - 585. FI: 8,272(Q1). DOI: 10.1136/jnnp-2018-319578.

Munoz, SG, Salazar, LM, Ocharan, MI, Garcia, SK, Garay, RP, Gredilla, FJA. Cerebrospinal fluid Tau protein as a marker of brain injury. Clin. Chim. Acta. 2019; 493: 610 - 610. FI: 2,735(Q2). DOI: 10.1016/j.cca.2019.03.1277.

Rafehi, Haloom, Szmulewicz, David J., Bennett, Mark F., Sobreira, Nara L. M., Pope, Kate, Smith, Katherine R., Gillies, Greta, Diakumis, Peter, Dolzhenko, Egor, Eberle, Michael A., Garcia Barcina, Maria, Breen, David P., Chancellor, Andrew M., Cremer, Phillip D., Delatycki, Martin B., Fogel, Brent L., Hackett, Anna, Halmagyi, G. Michael, Kapetanovic, Solange, Lang, Anthony, Mossman, Stuart, Mu, Weiyi, Patrikios, Peter, Perlman, Susan L., Rosemergy, Ian, Storey, Elsdon, Watson, Shaun R. D., Wilson, Michael A., Zee, David S., Valle, David, Amor, David J., Bahlo, Melanie, Lockhart, Paul J.. Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS. Am. J. Hum. Genet.. 2019; 105(1): 151 - 165. FI: 9,924(Q1). DOI: 10.1016/j.ajhg.2019.05.016.

Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, Azriel S, Eulalio Bárcena J, Cabezudo García P, Camacho Salas A, Casanova Rodríguez C, Cobo Esteban AM, Díaz Guardiola P, Fernández-Torrón R, Gallano Petit MP, García Pavía P, Gómez Gallego M, Gutiérrez Martínez AJ, Jericó I, Kapetanovic García S, López de Munaín Arregui A, Martorell L, Morís de la Tassa G, Moreno Zabaleta R, Muñoz-Blanco JL, Olivar Roldán J, Pascual Pascual SI, Peinado Peinado R, Pérez H, Poza Aldea JJ, Rabasa M, Ramos A, Rosado Bartolomé A, Rubio Pérez MÁ, Urtizberea JA, Zapata-Wainberg G, Gutiérrez-Rivas E. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease. Med. Clin.. 2019; 153(2): 82 - 82. FI: 1,277(Q3). DOI: 10.1016/j.medcli.2018.10.028.

De Brouwer, E., Peeters, L., Becker, T., Altintas, A., Soysal, A., Van Wijmeersch, B., Boz, C., Oreja-Guevara, C., Gobbi, C., Solaro, C., Ramo, C., Spitaleri, D. L., Maimone, D., Aguera-Morales, E., Cartechini, E., Butler, E., Havrdova, E., Patti, F., Granella, F., Grand'Maison, F., Moore, F., Verheul, F., Iuliano, G., Butzkueven, H., Lechner-Scott, J., Kuhle, J., Sanchez Menoyo, J. L., Rojas, J. I., Prevost, J., Onofrj, M., Rio, M. E., Sa, M. J., Saladino, M. L., Slee, M., Barnett, M., Terzi, M., Deri, N., McCombe, P., Sola, P., Duquette, P., Grammond, P., Ampapa, R., Alroughani, R., Hupperts, R., Turkoglu, R., Gouider, R., Fernandez Bolanos, R., Bergamaschi, R., Kalincik, T., Moreau, Y., MSBase Consortium. Introducing Machine Learning for full MS patient trajectories improves predictions for disability score progression. Mult. Scler. J.. 2019; 25: 63 - 65. FI: 5,649(Q1). DOI: .

Sharmin, S., Malpas, C., Horakova, D., Havrdova, E. K., Izquierdo, G., Eichau, S., Trojano, M., Prat, A., Girard, M., Duquette, P., Onofrj, M., Lugaresi, A., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Terzi, M., Hupperts, R., Alroughani, R., Boz, C., Shaygannejad, V., Van Pesch, V., Cartechini, E., Kappos, L., Lechner-Scott, J., Bergamaschi, R., Turkoglu, R., Solaro, C., Ramo-Tello, C., Iuliano, G., Granella, F., Van Wijmeersch, B., Spitaleri, D., Bolanos, R. F., Slee, M., McCombe, P., Prevost, J., Ampapa, R., Ozakbas, S., Sanchez-Menoyo, J. L., Soysal, A., Vucic, S., Petersen, T., Verheul, F., Butler, E., Hodgkinson, S., Sidhom, Y., Gouider, R., Butzkueven, H., Kalincik, T., MSBase Registry. Predicting long-term sustained disability progression in multiple sclerosis. Mult. Scler. J.. 2019; 25: 119 - 121. FI: 5,649(Q1). DOI: .

Rodrigo-Armenteros, Patricia, Kapetanovic-Garcia, Solange, Anton-Mendez, Lander, Jose Gomez-Muga, Juan, Bedia-Del Rio, Edurne, Angeles Fernandez-Cuesta, Maria, Carlos Garcia-Monco, Juan. Akinetic mutism and status epilepticus due to Epstein Barr virus encephalitis. Clin. Neurol. Neurosurg.. 2019; 185: 105492 - 105492. FI: 1,672(Q3). DOI: 10.1016/j.clineuro.2019.105492.

Bocos-Portillo J, Sánchez-Menoyo JL, Beldarrain MG, Saralegui-Prieto I, Ontañón-Garcés JM, Dalmau J, et al. Acute disseminated encephalomyelitis: A rare autoimmune complication of herpes simplex encephalitis in the adult. Clin. Neurol. Neurosurg.. 2018; 175: 47 - 49. FI: 1,736(Q3). DOI: 10.1016/j.clineuro.2018.10.007.

Lucas-Jimenez O, Ojeda N, Pena J, Cabrera-Zubizarreta A, Diez-Cirarda M, Gomez-Esteban JC, et al. Apathy and brain alterations in Parkinson's disease: a multimodal imaging study. Ann. Clin. Transl. Neurol. 2018; 5(7): 803 - 814. FI: 4,649(Q1). DOI: 10.1002/acn3.578.

Le MVH, Malpas C, Sharmin S, Horakova D, Havrdova EK, Trojano M, et al. Disability outcomes in patients with early cerebellar symptoms in multiple sclerosis. Mult. Scler. J. 2018; 24: 135 - 137. MEETING ABSTRACT.

Eichau S, Spelman T, Izquierdo G, Laffaldano P, Oreja-Guevara C, Butzkueven H, et al. Familial multiple sclerosis: comparing demographic and clinical characteristics with sporadic form. Mult. Scler. J. 2018; 24(2): 24 - 25. MEETING ABSTRACT.

Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018; 17(9): 760 - 772. FI: 27,138(Q1). DOI: 10.1016/S1474-4422(18)30244-8.

Signori A, Izquierdo G, Lugaresi A, Hupperts R, Grand'Maison F, Sola P, et al. Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis. Mult. Scler. J. 2018; 24(5): 642 - 652. FI: 5,280(Q1). DOI: 10.1177/1352458517703800.

Diez-Cirarda M, Ojeda N, Pena J, Cabrera-Zubizarreta A, Lucas-Jimenez O, Gomez-Esteban JC, et al. Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson's disease. Eur. J. Neurol. 2018; 25(1): 5 - 12. FI: 4,621(Q1). DOI: 10.1111/ene.13472.

Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, et al. Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod. Mult. Scler. Relat. Disord.. 2018; 19: 105 - 108. FI: 3,199(Q2). DOI: 10.1016/j.msard.2017.11.018.

Garcia-Monco JC, Gomez-Beldarrain MA, Pinedo-Brochado AC, Rodriguez-Sainz A. Preventive therapy with citalopram added to a beta blocker does not result in quality-of-life improvement in patients with episodic migraine. Cephalalgia Reports. 2018; FI: (Q). DOI: 10.1177.

Ahmed F, Gaul C, Martelletti P, Garcia-Monco JC, Adams AM. Real-Life Use of OnabotulinumtoxinA for the Symptomatic Treatment of Chronic Migraine: The REPOSE Study. Neurology. 2018; 90. MEETING ABSTRACT.

Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, et al. Reply to: Comment on YD Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)]. Mult. Scler. Relat. Disord. 2018; 22: 166 - 166. FI: 3,199(Q2). DOI: 10.1016/j.msard.2018.02.025. EDITORIAL MATERIAL.

Min M, Spelman T, Lugaresi A, Boz C, Spitaleri DLA, Pucci E, et al. Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis. Mult. Scler. J. 2018; 24(12): 1569 - 1577. FI: 5,280(Q1). DOI: 10.1177/1352458518798147.

Fernández-Vega I, Díaz-Lucena D, Azkune Calle I, Geijo M, Juste RA, Llorens F, et al. Sporadic Creutzfeldt-Jakob disease with glial PrPRes nuclear and perinuclear immunoreactivity. Neuropathology. 2018; 38(5): 561 - 567. FI: 1,887(Q3). DOI: 10.1111/neup.12505.

Pardina-Vilella L, Pinedo-Brochado A, Vicente I, Bocos-Portillo J, Martínez-Arroyo A, Ontañon JM, et al. The goblet sign in the amnestic syndrome of the subcallosal artery infarct. Neurol. Sci. 2018; 39(8): 1463 - 1465. FI: 2,285(Q3). DOI: 10.1007/s10072-018-3425-z.

Bocos-Portillo J, Escalza-Cortina I, Gómez-Beldarrain M, Rodriguez-Sainz A, Garcia-Monco JC. Unilateral or bilateral punctate hippocampal hyperintensities on DW-MRI: seizures, amnesia, or both? Neurol. Sci. 2018; 39(9): 1647 - 1649. FI: 2,285(Q3). DOI: 10.1007/s10072-018-3461-8.